Commercial and Medical Alignment: Why It Still Fails and How to Fix It
Every pharma company says Medical and Commercial should work together. Most have run the workshop. Some have run it twice. And a few months later, the two functions are planning separately again, meeting mainly when a launch is at risk or a piece of content is stuck in review.
The problem is not goodwill. Most people on both sides want this to work. The problem is structural, and workshops do not fix structure.
Alignment does not mean blurring the line
First, clear away the wrong definition. Alignment does not mean Medical Affairs supporting promotion, sharing what experts said about a competitor with the sales team, or softening scientific positions to fit a brand message.
Real alignment means both functions work towards the same patient and business outcomes, each within its own role. Medical Affairs brings evidence, scientific insight and credibility with the expert community. Commercial brings market understanding, customer reach and resources. The boundary between them is what makes Medical Affairs credible. Strong alignment protects it.
Why it keeps failing
In most organisations, four structural issues pull the functions apart.
Different measures of success. Commercial is measured on sales, share and growth. Medical Affairs is often measured on activity: interactions, advisory boards, publications. When success is defined differently, priorities drift, however good the relationships.
Different planning rhythms. Brand plans are built on one calendar. Medical plans on another. By the time Medical Affairs sees the brand strategy, the key choices are made, and Medical's input becomes commentary rather than direction.
No structured way to share insight. Field medical teams hear things that matter to strategy: unmet needs, treatment barriers, questions about the evidence. Without an agreed, compliant route for non-promotional insights to reach brand and access planning, they stay in the CRM.
Unclear decision rights. Who decides the scientific narrative? Who signs off the evidence priorities? When nobody knows, every decision becomes a negotiation, and the louder function usually wins.
Four fixes that work
These are the changes that consistently move alignment from intention to practice.
1. Agree shared outcomes, and separate measures. Start with two or three patient and business outcomes both functions care about, such as earlier diagnosis in a defined population or guideline adoption. Then define what each function contributes and how it is measured. Medical Affairs measures might include evidence gaps closed or insight themes adopted into plans. Shared outcomes, different roles.
2. Plan on one calendar. Bring the medical and brand planning cycles together, with Medical Affairs input at the start of strategy setting, not at review. A joint planning session where both teams review the same evidence, insights and market data changes the quality of decisions more than any number of follow-up meetings.
3. Build a compliant insight pipeline. Define which insights can be shared, in what form, how often, and who receives them. Aggregated, non-promotional and focused on unmet need and evidence gaps. Then close the loop: tell the field team what changed because of their insight. That one step improves insight quality more than any training.
4. Write down decision rights. A simple RACI for the decisions that matter: scientific narrative, evidence generation priorities, advisory board objectives, congress strategy, materials that need medical sign-off. It removes most of the friction that people currently blame on personalities.
What it looks like when it works
Picture a launch in a specialty therapy area. MSLs keep hearing the same thing from experts: the pivotal trial excluded the older, frail patients they see most often, so they hesitate to prescribe.
In a misaligned organisation, that insight sits in the CRM. The brand team builds messaging around the headline efficacy result. Sales reports slow uptake in exactly that population, and nobody connects the two.
In an aligned organisation, the insight reaches the quarterly review as a theme with supporting evidence. Medical Affairs proposes a real-world evidence project and an educational programme on the data that does exist for older patients. Commercial adjusts its targeting assumptions and resource plans. Each function acts within its own role. The patient group that was being missed gets attention, because the structure made the insight travel.
That is the whole argument for alignment. Not friendlier meetings. Better decisions, made earlier, on the basis of evidence.
What leaders can do this quarter
If you lead Medical Affairs, three moves make a visible difference within 90 days:
- Ask your Commercial counterpart for a joint session to agree two shared outcomes for next year.
- Review your current KPIs and replace at least one activity measure with an impact measure.
- Pilot a quarterly, compliant insight report to brand and access teams, with a clear "so what" for each theme.
If you lead Commercial, invite Medical Affairs into strategy setting before the plan is drafted, and ask what evidence and insight would change your assumptions.
The test of real alignment
Here is a simple test. In your last brand or launch plan, can you point to one decision that changed because of Medical Affairs insight? If you can, the alignment is real. If you cannot, the workshops have not done their job yet.
Which side of that test is your organisation on today? If you want to talk it through, book a 20-minute call, or see how the Medical-Commercial Alignment Programme works.